Microplastics and Inflammation: An Emerging Environmental Threat to Immune Health

Microplastics, defined as plastic particles smaller than 5 millimeters, and nanoplastics, smaller than 1 micrometer, are now ubiquitous in the global environment, detectable in Arctic ice, deep ocean sediments, mountain snowpack, drinking water, food, and the air of indoor and outdoor environments worldwide. Humans are continuously exposed through ingestion of contaminated food and water, inhalation of airborne plastic particles, and dermal contact with plastic-containing products.

Until recently, the health consequences of this exposure were speculative. A cascade of recent findings has changed this. A landmark 2024 study published in the New England Journal of Medicine detected microplastics and nanoplastics in carotid artery plaques of patients undergoing endarterectomy, and patients with detectable plastic in their plaques had a 4.5-fold higher rate of myocardial infarction, stroke, or death over the following 34 months. This finding transformed the microplastics-health discussion from an environmental science concern to an urgent cardiovascular medicine question.

How Microplastics Enter the Body and Where They Accumulate

The primary routes of human microplastic exposure are dietary, respiratory, and increasingly well-characterized in research. The average person is estimated to ingest between 39,000 and 52,000 microplastic particles annually through food and beverages, with seafood, bottled water, table salt, and foods packaged in plastic contributing the largest dietary loads. Heating food in plastic containers accelerates leaching of plastic particles into food, making microwave-safe plastic labeling a misleading safety assurance rather than confirmation of health neutrality.

Once ingested or inhaled, microplastics distribute widely through the body. Studies have detected polyethylene, polypropylene, PET, and polystyrene particles in human blood, with concentrations in venous blood averaging approximately 1.6 micrograms per milliliter in a 2022 Environmental International study. Tissue distribution studies have found microplastics in the lungs, liver, spleen, kidney, colon, placenta, and as noted in the 2024 NEJM paper, in arterial plaques. The blood-brain barrier, while less studied, appears permeable to nanoplastic particles in animal studies, raising concerns about central nervous system accumulation.

Inflammatory Responses to Plastic Particles

Macrophages, the primary cellular responders to foreign particles in tissues, attempt to phagocytose microplastic particles but cannot degrade them. This creates a frustrated phagocytosis response in which macrophages persistently attempt to engulf indigestible particles, producing sustained TNF-alpha, IL-1 beta, and IL-6 in a pattern resembling the response to asbestos fibers or crystalline silica. The NLRP3 inflammasome is activated by microplastic particles through a lysosomal damage mechanism similar to that triggered by monosodium urate crystals in gout.

Beyond their direct physical inflammatory effects, microplastics carry adsorbed chemical contaminants including polychlorinated biphenyls (PCBs), polycyclic aromatic hydrocarbons (PAHs), and phthalate plasticizers that have independent inflammatory and endocrine-disrupting effects. These chemical co-contaminants amplify the inflammatory response to plastic particles and may explain why inflammatory effects in animal models sometimes exceed what would be expected from the particles' physical properties alone. The 2024 arterial plaque study found that the plastic particles in cardiovascular plaques were associated with higher local concentrations of inflammatory markers and immune cell infiltration than plaque regions without plastic, consistent with a direct inflammatory role in plaque instability and vulnerability.

What We Know and What Remains Uncertain

The science of microplastics and human health is rapidly evolving, and important uncertainties remain. The dose-response relationship between microplastic exposure and specific health outcomes has not been fully characterized in humans. The relative contribution of microplastic size, polymer type, surface chemistry, and adsorbed contaminants to their inflammatory effects is incompletely understood. Long-term prospective studies tracking health outcomes in relation to measured body burden of microplastics are scarce, largely because the field has only recently developed reliable methods for detecting and quantifying plastics in biological tissues.

What is clear from the current evidence is that microplastic accumulation in human tissues is real, widespread, measurable, and associated in the available data with inflammatory responses and cardiovascular outcomes that warrant serious preventive attention. The precautionary principle, supported by the rapidly accumulating evidence, justifies reducing avoidable microplastic exposures now without waiting for definitive dose-response data that may take decades to generate.

Practical Steps to Reduce Microplastic Exposure

While complete elimination of microplastic exposure is impossible given their ubiquity, several practical strategies meaningfully reduce the highest-exposure sources. Switching from bottled water to filtered tap water is one of the highest-impact changes: bottled water contains an average of 325 microplastic particles per liter versus approximately 5 per liter in tap water, and using a high-quality home filter (reverse osmosis or NSF-53 certified) further reduces tap water particles. Avoiding heating food in plastic containers, replacing plastic food storage with glass or stainless steel, and reducing consumption of ultra-processed foods (which typically involve extensive plastic packaging contact during manufacturing) each reduce dietary exposure meaningfully.

Indoor air quality management matters as well: synthetic carpets, upholstery, and fleece fabrics shed microfibers that become airborne, and regular vacuuming with HEPA filtration, along with choosing natural fiber flooring and textiles where feasible, reduces inhalation exposure. Sea salt, which is processed near ocean environments and is a significant microplastic source, can be replaced with Himalayan or rock salt. These are not solutions to the systemic environmental microplastic problem, which requires regulatory and industrial action, but they are meaningful individual steps for reducing personal exposure while the science and policy continue to develop.